Journal of Veterinary Diagnostic Investigation · 2006 · 18 citations · 18 references
MedicineHematologyPathologyHematologic OncologyHematopathologyHistopathologyBone Marrow PathologyClinical HematologyHematologic MalignanciesHematologic PathologyImmunohistochemistryTumor AntigensHistological CharactersImmunohistochemical BiomarkersImmunohistochemical DetectionImmunohistochemical MarkersImmunohistochemical StainingLeukemia PathologyParaffin-embedded Tissue StainingVon Willebrand Factor Antigen
The clinical, hematological, and histopathologic features of megakaryoblastic leukemia (M7) were investigated in a 10-year-old female Shih-Tzu dog. Megakaryoblastic leukemia was diagnosed using anti-human platelet glycoprotein (GP IIIa) and anti-human von Willebrand factor (vWF) antibodies. The expression of CD antigen on megakaryoblasts was also assessed using a CD79a monoclonal antibody. Immunological markers allowed visualization of neoplastic megakaryocytes. Antibodies against platelet GP IIIa were demonstrated to be the most useful for the diagnosis of megakaryoblastic leukemia of paraffin-embedded canine tissues. Hematological and histological data coupled with immunohistochemical reactivity for platelet GP IIIa, vWF, and CD79a antigen in blast cells confirmed a diagnosis of M7 megakaryoblastic leukemia.
18
Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experience.
Martin S. Tallman, Donna Neuberg, John M. Bennett et al. · PubMed · 2000 · 141 citations
Medicine, Hematology, Oncology +14
Leukemias with megakaryoblastic involvement: clinical, hematologic, and immunologic characteristics
Jesús F. San Miguel, Marcos González, MC Cañizo et al. · Blood · 1988 · 110 citations · Full text
Medicine, Hematology, Oncology +14
Megakaryoblastic leukemia: the characterization and identification of megakaryoblasts
T Koike · Blood · 1984 · 107 citations · Full text
Medicine, Hematology, Oncology +12